While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...

The governing board of the State Health Plan is expected to give state treasurer Brad Briner the go-ahead Friday to overhaul ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Welcome to the full-year 2024 Novo Nordisk earnings conference call. [Operator instructions] Please be advised that today's ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

Wegovy (semaglutide) is an injection medication ... it for a sustained period results in a reduction of body weight. Saxenda (liraglutide) is a GLP-1 that increases feelings of fullness while ...

He spoke on the chances of getting popular weight loss drugs like Saxenda and Wegovy covered again for state employees, future premium increases and more. Briner announced soon after taking office ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Rep. Chip Roy (R-TX) issued a diagnosis for America’s broken health care system, and the congressman says the problem isn’t what people think.

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...